Cell Separation Market was valued at USD 136 billion by 2020, growing with 8.6% CAGR during the forecast period, 2021-2030.
Cell separation is a technique for sorting cells into particular populations from a diverse bunch of cells without contaminating them. Cell isolation is dependent on cell characteristics such as surface charge and adhesion, cell size and density, surface markers, and a few others. The use of cell isolation methods contributes to the advancement of cell-based treatments and, as a result, improves treatment quality and clinical outcomes.Cell separation is a potent technique that is widely utilized in many areas of biological and biomedical research, as well as therapeutic therapy. Cell separation strategies are widely divided into two types: those based on physical characteristics (size/density) and those based on affinity (chemical, electrical, or magnetic couplings).Therapeutic cell separation enables the administration of enriched cell populations to patients with clinical needs. Advances in stem cell treatment, tissue engineering, and regenerative medicine are demonstrating the feasibility of clinical cell-based therapies generated from a range of tissues. Cell separation has applications such as extracting circulating tumour cells from blood, separating harmful germs from food, and isolating immune cells from peripheral blood.
Market Dynamics and Factors:
According to the World Health Organization (WHO), Cancer accounted for nearly 10 million deaths in 2020 which created massive demand for the cell separation market growth for the cancer patient treatment. Cancer illness accounts for around one-sixth of all fatalities worldwide.Increase in the number of cancer patients, as well as patients suffering from many other infectious illnesses, is expected to play an essential role in the development of the worldwide cell separation market from 2020 to 2030. Furthermore, increasing government support for cell-based research, as well as a greater emphasis on technical developments and customised treatment, are expected to drive growth in the worldwide cell separation market in the coming years. Increasing investment and emphasis on R&D by numerous biopharmaceutical and biotechnological firms is projected to drive demand for consumables and instruments.
Global Cell Separation Market Segmentation:
Global cell separation market can be segmented on the basis of by product type (Reagents, kits, media, beads, disposables, centrifuges, flow cytometers, filtration systems, magnetic-activated cell separator systems), By application (Biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnosticstherapeutics),By Technology (Centrifugation- based cell isolation, Surface marker- based cell isolation, Filtration- based cell isolation)By Cell Type (Animal Cell, Human Cell) By Market Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).
Geographic Analysis:
Over the projected period, North America share is estimated to have the highestcell separation market share in the Cell Isolation/Cell Separation Market, followed by Europe. The growing government backing for cancer and stem cell research, the developing biotechnology and biopharmaceutical sectors, and the rising prevalence of chronic and infectious illnesses that necessitate cell isolation for diagnosis and treatment all contribute to this market segment's size. As a result, demand for cell isolation products rises. The increasing cases of chronic illnesses have contributed the highest expansion of the cell separation technologies market in Asia. China and India are projected to be Asia's fastest developing markets for cell separation technology.
Competitive Scenario:
The cell separation market share, which is highly competitive, consists of a few major players. In terms of cell separation market share, few of the major players currently dominate the market. The key players of cell separation market areio-Rad Laboratories, Inc., MitenyiBiotec GmbH, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., Stemcell Technologies Inc., Merck KGaA, GE Healthcare, Luminex Corporation, pluriSelect Life Science UG, SysmexEurope GmbH, Becton, Dickinson and Company, EMD Millipore (Merck Group), Terumo BCT, Inc. and many more.
Cell Separation Market Report Scope
Report Attribute | Details |
Market size value in 2020 | USD 136 billion |
Growth Rate | CAGR of 8.6% from 2021 to 2030 |
Forecast period | 2021 - 2030 |
Quantitative units | Revenue in USD billion 2020 to 2030 and CAGR from 2021 to 2030 |
Report coverage | Revenue forecast, Market Share Analysis, Sales Analysis, Competitor Analysis, Growth factors, and trends, Macro-economic indicator analysis, PORTER's Five Forces analysis, Pricing Analysis, PESTEL Analysis, Value Chain Analysis, COVID-19 Impact Analysis |
Segments covered | By Product Type (Reagents, kits, media, Beads, Disposables, Centrifuges, Flow cytometers, Filtration systems, Magnetic-activated cell separator systems) By Application (Biomolecule isolation, Cancer research, Stem cell research, Tissue regeneration, In vitro diagnostics Therapeutics ),By Technology (Centrifugation- based cell isolation, Surface marker- based cell isolation, Filtration- based cell isolation)By Cell Type (Animal Cell, Human Cell) |
Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
Key Country scope | U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; Japan; China; India; Malaysia; Singapore; South Korea; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Turkey |
Key companies profiled | areio-Rad Laboratories, Inc., MitenyiBiotec GmbH, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., Stemcell Technologies Inc., Merck KGaA, GE Healthcare, Luminex Corporation, pluriSelect Life Science UG, SysmexEurope GmbH, Becton, Dickinson and Company, EMD Millipore (Merck Group), Terumo BCT, Inc. and many more. |